A 137491

Drug Profile

A 137491

Alternative Names: ABT 491

Latest Information Update: 29 Jan 2013

Price : $50

At a glance

  • Originator Abbott Laboratories
  • Class Anti-inflammatories; Antiallergics; Antiasthmatics; Indoles
  • Mechanism of Action Platelet activating factor inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Allergic rhinitis

Most Recent Events

  • 30 Jul 1999 Profile reviewed
  • 14 Feb 1997 Investigation in Allergic rhinitis in USA (Unknown route)
  • 08 Aug 1996 An in vivo study has been added to the pharmacokinetics and pharmacodynamics sections
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top